Navigation Links
Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
Date:11/15/2011

TUSTIN, Calif., Nov. 15, 2011 /PRNewswire/ -- On November 14, 2011, DHS Holding Co. (DHS) issued a press release announcing it will enter into preliminary talks with Radient Pharmaceuticals Corporation (OTCQX:RXPC) (OTCPK:RXPC), to discuss business opportunities that would benefit both parties.  However, that press release was issued without our approval and we do not intend to have any further discussions, or enter into any business opportunities with DHS.

On today's date, our attorneys requested DHS to immediately retract the press release at issue.

The following table is intended to provide the latest information on Radient's business metrics.Radient's Business MetricsCash on hand: $54,000*

*Approximate amount as of November 15, 2011Common Shares Outstanding:  746 million*

*Approximate number as of November 15, 2011.

  5 billion shares authorized.Outstanding Warrants & Options:  110 million*

*Approximate number as of  November 15, 2011About Radient Pharmaceuticals:Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared In Vitro Diagnostic Onko-Sure® cancer test kit for colorectal cancer treatment and recurrence monitoring. The Company's focus is on the discovery, development and commercialization of unique high-value diagnostic tests that will help physicians answer important clinical questions related to early disease state detection, treatment strategy, and the monitoring of disease progression or recurrence. To learn more about our company, products, and potentially life-saving cancer test, visit www.radient-pharma.com.

Forward-Looking Statements:Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predic
'/>"/>

SOURCE Radient Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Radient Pharmaceuticals Announces FY 2011 Third Quarter Results
2. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
3. Radient Pharmaceuticals Corporation Joins OTCQX
4. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
5. The Outlook for Pharmaceuticals in South East Asia
6. The Outlook for Pharmaceuticals in Western Europe
7. The Outlook for Pharmaceuticals in Central & Eastern Europe
8. The Outlook for Pharmaceuticals in the Middle East and North Africa
9. The Outlook for Pharmaceuticals in Brazil, Russia, India & China
10. The Outlook for Pharmaceuticals in Latin America
11. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... DIEGO , Oct. 20, 2014  AnaptysBio, ... of therapeutic antibodies, today announced the appointment of ... Officer. Dr. Londei will lead the preclinical and ... "We are pleased to welcome Dr. ... Hamza Suria , President and Chief Executive Officer ...
(Date:10/20/2014)... Oct. 20, 2014 Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, received official notification from the European ... another key patent supporting its iSONEP™ and ASONEP™ ... European patent No. 2087002, claims compositions of matter ... two lead compounds, iSONEP and ASONEP. Sonepcizumab is ...
(Date:10/20/2014)... , Oct. 20, 2014   Mary,s Medicinals ... for Caring, is a 4-Star Sponsor of Operation ... Veterans with unique products, programs and services to assist ... freedom. Key Facts: , An ... is a safe and effective treatment for pain, Post-traumatic ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3
... N.J., Feb. 27, 2012    Octapharma USA has submitted ... the U.S. Food and Drug Administration (FDA) with ... fourth quarter of 2012. The FDA will evaluate ... preoperative or bleeding patients who require replacement of multiple plasma ...
... ST. LOUIS, Feb. 27, 2012 Stereotaxis, Inc. (NASDAQ: ... release financial results for the fourth quarter and full ... 2012 after the close of the U.S. financial markets.  ... at 4:30 p.m. Eastern Time that day to discuss ...
Cached Medicine Technology:Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events 2Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events 3Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012 2Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012 3
(Date:10/20/2014)... Washington, D.C. (PRWEB) October 20, 2014 Zereana ... was crowned Mrs. Maryland 2014 on a platform to think ... battle scars, and uses her position to raise awareness about ... on awareness for breast cancer. You say the color pink ... “But I know for a fact that it has not ...
(Date:10/20/2014)... Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, ... all the latest information from the FDA on Sit ... on October 10 not to purchase or use Sit and ... Sit and Slim II is promoted as weight loss product ... Sibutramine, removed from the market in 2010 for safety reasons, ...
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... hard to imagine what it’s like to live without shoes, ... it’s a reality. And while new shoes are considered a ... barefoot on rocky terrain or sewage-lined streets just to collect ... , Buckner International's Shoes for Orphan Souls project ... encourage support for Air1 and while also providing new shoes ...
(Date:10/19/2014)... and Hastings, a Phoenix personal injury law firm with ... area and across Arizona reports record demand in 2014 ... Statistics have indicated a steady increase in automobile accidents ... and Hastings has seen a steady increase in the ... injured through no fault of their own that is ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... Medicare Claims Denials by 50% and IVANS LIME Is Ten Times ... ... 18, 2009 -- IVANS , the leading provider of corporate ... Verification solution has helped Mobile X-Ray Imaging Inc. significantly reduce ...
... DALLAS, Feb. 18 Every week more than 3,000 people in ... many find themselves with insufficient coverage or lack of insurance to ... , , The Limbs for Life Foundation ... and provide them with financial assistance to return to productive jobs ...
... their meat. Whether it,s rib eyes, pork chops or chicken ... country that more than 85 billion pounds of meat and ... a quarter of U.S. beef and pork is exported to ... the world,s largest consumer of meat, in Mexico, meat consumption ...
... pressure medication may be the key to preventing brain ... newly published study by researchers at Wake Forest University ... of an improved quality of life for cancer patients. ... a hypothesis from previous studies that a compound similar ...
... , A research group of the Universities of Granada ... food craving, an irresistible desire for eating certain foods (sweets, ... out by Professors Silvia Moreno Domnguez (University of ... and M Carmen Fernndez-Santaella ( University of Granada ...
... by Cop" (SBC) is a suicide method in which a ... an attempt to get oneself killed or injured by law ... Sciences examined the prevalence of this phenomenon among a ... SBC occurs at extremely high rates, with 36 percent of ...
Cached Medicine News:Health News:IVANS Helps Mobile X-Ray Imaging Inc. Reduce Its Costs for Uncompensated Care 2Health News:IVANS Helps Mobile X-Ray Imaging Inc. Reduce Its Costs for Uncompensated Care 3Health News:Limbs for Life Foundation to Host 8th Annual Fundraiser and Live Auction 2Health News:American Veterinary Medical Association: Weaving a Web for Food Safety 2Health News:Blood pressure compound may benefit brain tumor patients 2Health News:Blood pressure compound may benefit brain tumor patients 3Health News:Several studies prove self-banning certain foods may cause food craving 2Health News:'Suicide by cop' phenomenon occurring in over a third of North American shootings involving police 2
... Processing Video Camera is our new generation ... Image Processing (IP) technology, the IP 4.2 ... Exciting new features, enhanced image quality, and ... exceptional value. All IP 4.2 cameras are ...
... full lineup of high-powered Xenon, Metal ... optimal brightness in a durable, lightweight ... highest quality light guide cables, providing ... lightweight, durable design., Powerful illumination and ...
... Due to its design, this ... varieties of stone therapy in urinary ... primarily as a multipurpose lithotripter with ... and percutaneous nephrolithotomy. ,The basic system ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: